FR2333494B1 - - Google Patents

Info

Publication number
FR2333494B1
FR2333494B1 FR7636554A FR7636554A FR2333494B1 FR 2333494 B1 FR2333494 B1 FR 2333494B1 FR 7636554 A FR7636554 A FR 7636554A FR 7636554 A FR7636554 A FR 7636554A FR 2333494 B1 FR2333494 B1 FR 2333494B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7636554A
Other languages
French (fr)
Other versions
FR2333494A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of FR2333494A1 publication Critical patent/FR2333494A1/fr
Application granted granted Critical
Publication of FR2333494B1 publication Critical patent/FR2333494B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
FR7636554A 1975-12-05 1976-12-03 Procede de stabilisation de derives de la pyrido-(3,2-a)-phenoxazine et solution stabilisee obtenue Granted FR2333494A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50145450A JPS5270014A (en) 1975-12-05 1975-12-05 Stabilization of pyrido*3*22a*phenoxadine compounds

Publications (2)

Publication Number Publication Date
FR2333494A1 FR2333494A1 (fr) 1977-07-01
FR2333494B1 true FR2333494B1 (US06272168-20010807-M00014.png) 1981-08-14

Family

ID=15385494

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7636554A Granted FR2333494A1 (fr) 1975-12-05 1976-12-03 Procede de stabilisation de derives de la pyrido-(3,2-a)-phenoxazine et solution stabilisee obtenue

Country Status (9)

Country Link
US (1) US4092410A (US06272168-20010807-M00014.png)
JP (1) JPS5270014A (US06272168-20010807-M00014.png)
DE (1) DE2654942A1 (US06272168-20010807-M00014.png)
ES (1) ES453970A1 (US06272168-20010807-M00014.png)
FR (1) FR2333494A1 (US06272168-20010807-M00014.png)
GB (1) GB1563734A (US06272168-20010807-M00014.png)
GR (1) GR62107B (US06272168-20010807-M00014.png)
PH (1) PH12790A (US06272168-20010807-M00014.png)
PT (1) PT65929B (US06272168-20010807-M00014.png)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220636A (en) * 1978-11-07 1980-09-02 Deutsche Gesellschaft fuer Unwelt-Schutz e. V. Stabilized suppositories containing ergo-alkaloids
JPS61144095U (US06272168-20010807-M00014.png) * 1985-02-26 1986-09-05
US4837239A (en) * 1985-08-23 1989-06-06 Syntex (U.S.A.) Inc. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
ATE72668T1 (de) * 1985-09-24 1992-03-15 Hoffmann La Roche Chinolinderivate.
JPS6322584A (ja) * 1986-07-15 1988-01-30 Senjiyu Seiyaku Kk 1−ハイドロキシ−5−オキソ−5H−ピリド〔3,2−a〕フエノキサジン−3−カルボン酸エステル類
CA2038716A1 (en) * 1990-03-28 1991-09-29 Yoshio Ueda Stabilizer for 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide-containing preparation, stabilizing method thereof and drug stabilized thereby
US5286480A (en) * 1992-06-29 1994-02-15 The Procter & Gamble Company Use of N-acetylated amino acid complexes in oral care compositions
KR100188318B1 (ko) * 1993-04-28 1999-06-01 고오야 마사시 안정화된 주사제 및 주사제의 안정화법
US6436972B1 (en) 2000-04-10 2002-08-20 Dalhousie University Pyridones and their use as modulators of serine hydrolase enzymes
TR200900881A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
TR200900882A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.
CN111202711B (zh) 2013-09-11 2022-06-21 伊戈尔生物药品股份有限公司 包含有机磷酸酯的液体蛋白质制剂
EP3200804A4 (en) 2014-10-01 2018-04-18 Eagle Biologics, Inc. Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
EP3688115A2 (en) 2017-09-25 2020-08-05 Northeastern University Biologically-inspired compositions that enable visible through infrared color changing compositions
CN108558906A (zh) * 2018-05-21 2018-09-21 日照市普达医药科技有限公司 一种治疗白内障药物苯并吩噁嗪类化合物及其制备方法
JP2023546290A (ja) * 2020-10-16 2023-11-01 シースパイア, インコーポレイテッド キサントマチンを抗酸化剤およびuvフィルター安定化剤として含有する光防御化粧品組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2719812A (en) * 1953-08-07 1955-10-04 Merck & Co Inc Stabilized aqueous solutions of streptomycin
US3132993A (en) * 1955-03-30 1964-05-12 Bristol Myers Co Tetracycline formulations stabilized by bisulfittes
US3169092A (en) * 1963-09-26 1965-02-09 Richardson Merrell Inc Stabilization of amines by tartrazine and bisulfite
US3429967A (en) * 1965-05-17 1969-02-25 Ciba Geigy Corp Stable neomycin solution
US3526698A (en) * 1968-04-11 1970-09-01 Merck & Co Inc Stabilization of levo-3-(3,4-dihydroxyphenyl)-2-methylalanine with sodium bisulfite and sorbitol
US3808317A (en) * 1969-10-29 1974-04-30 Alcon Labor Inc Stabilized aqueous borate complexes of biologically active catechol amines
US3777019A (en) * 1971-02-03 1973-12-04 American Home Prod Stabilized chlorpromazine hydrochlo-ride solution for use in disposable cartridges
US3734742A (en) * 1971-12-08 1973-05-22 Merck & Co Inc Stabilized beverages

Also Published As

Publication number Publication date
DE2654942A1 (de) 1977-06-08
DE2654942C2 (US06272168-20010807-M00014.png) 1988-02-04
FR2333494A1 (fr) 1977-07-01
PT65929A (en) 1977-01-01
JPS5270014A (en) 1977-06-10
US4092410A (en) 1978-05-30
JPS5510570B2 (US06272168-20010807-M00014.png) 1980-03-17
PH12790A (en) 1979-08-17
PT65929B (en) 1978-06-13
GB1563734A (en) 1980-03-26
ES453970A1 (es) 1978-04-01
GR62107B (en) 1979-02-26

Similar Documents

Publication Publication Date Title
FR2392363B1 (US06272168-20010807-M00014.png)
FR2333494B1 (US06272168-20010807-M00014.png)
JPS5710825B2 (US06272168-20010807-M00014.png)
FR2321994B1 (US06272168-20010807-M00014.png)
JPS51108981U (US06272168-20010807-M00014.png)
JPS5318078Y2 (US06272168-20010807-M00014.png)
JPS5547035Y2 (US06272168-20010807-M00014.png)
JPS5526738B2 (US06272168-20010807-M00014.png)
JPS5738605B2 (US06272168-20010807-M00014.png)
JPS51104489U (US06272168-20010807-M00014.png)
JPS5288427U (US06272168-20010807-M00014.png)
JPS525259U (US06272168-20010807-M00014.png)
CH605559A5 (US06272168-20010807-M00014.png)
CH604691A5 (US06272168-20010807-M00014.png)
CH607333A5 (US06272168-20010807-M00014.png)
BG20954A1 (US06272168-20010807-M00014.png)
BG21466A1 (US06272168-20010807-M00014.png)
BG21726A1 (US06272168-20010807-M00014.png)
BG22964A1 (US06272168-20010807-M00014.png)
CH585096A5 (US06272168-20010807-M00014.png)
CH587977A5 (US06272168-20010807-M00014.png)
CH607005A5 (US06272168-20010807-M00014.png)
CH606630A5 (US06272168-20010807-M00014.png)
CH606521A5 (US06272168-20010807-M00014.png)
CH608628A5 (US06272168-20010807-M00014.png)

Legal Events

Date Code Title Description
ST Notification of lapse